Inflectra Approved as 'Biosimilar' to Remicade

WEDNESDAY, April 6, 2016 -- The U.S. Food and Drug Administration has approved its second-ever "biosimilar" drug, Inflectra, for adults with Crohn's disease, rheumatoid arthritis or chronic plaque psoriasis, among other prescribed uses. In a media...
Source: Drugs.com - Daily MedNews - Category: Journals (General) Source Type: news